Crossmark

CRISPR-engineered microbiome: living therapeutics revolutionize blood cancer immunotherapy

Crossref DOI link: https://doi.org/10.1038/s41522-025-00882-9

Published Online: 2025-12-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cheng, Fang

Soleimani Samarkhazan, Hamed https://orcid.org/0000-0003-1045-7613
Khazaei, Yeganeh https://orcid.org/0009-0003-1955-5022
License Information

Text and Data Mining valid from 2025-12-13

Version of Record valid from 2026-01-19
More Information

Article History

Received: 25 August 2025

Accepted: 29 November 2025

First Online: 13 December 2025

Competing interests

: The authors declare no competing interests.